Although no direct evidence focusing on the involvement of MEG3 in cerebral ischemic injury, it was genetic phenotype silenced in brain disease and has been recognized as a novel potentially tumor-suppressing RNA in meningioma and glioma cell (Wang et al., 2012; Ouyang et al., 2014). Here, MEG3 is linked to neoplasm.